Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
Haemonetics reports 2020 executive compensation
By ExecPay News
Published: June 8, 2020
Haemonetics reported fiscal year 2020 executive compensation information on June 8, 2020.
In 2020, five executives at Haemonetics received on average a compensation package of $3.5M, a 11% increase compared to previous year.
Average pay of disclosed executives at Haemonetics
Christopher Simon, Chief Executive Officer, received $9.4M in total, which increased by 10% compared to 2019. 58% of Simon's compensation, or $5.5M, was in stock awards. Simon also received $1.6M in non-equity incentive plan, $1.4M in option awards, $937K in salary, as well as $29K in other compensation.
For fiscal year 2020, the median employee pay was $43,875 at Haemonetics. Therefore, the ratio of Christopher Simon's pay to the median employee pay was 214 to one.
William P. Burke, Chief Financial Officer, received a compensation package of $2.6M, which increased by 12% compared to previous year. 46% of the compensation package, or $1.2M, was in stock awards.
Michelle L. Basil, General Counsel, earned $2.5M in 2020, a 18% increase compared to previous year.
Josep L. Llorens, Senior Vice President, Global Manufacturing and Supply Chain, received $1.6M in 2020.
Jacqueline D. Scanlan, Senior Vice President, Global Human Resources, earned $1.5M in 2020, a 4% increase compared to previous year.
Haemonetics' fiscal year ends on April 2.
Related executives
Christopher Simon
Haemonetics
Chief Executive Officer
William Burke
Haemonetics
Chief Financial Officer
Michelle Basil
Haemonetics
General Counsel
Josep Llorens
Haemonetics
Executive Vice President, Global Manufacturing and Supply Chain
Jacqueline Scanlan
Haemonetics
Senior Vice President, Global Human Resources
You may also like
Source: SEC filing on June 8, 2020.